Glycaemic control in type 1 diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study (Q43771069)

26 November 2017

Glycaemic control in type 1 diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study (English)

1 reference

26 November 2017

1 reference

2

1 reference

26 November 2017

G Tamás

1

1 reference

26 November 2017

R Astorga

3

1 reference

26 November 2017

I Dedov

4

1 reference

26 November 2017

J Jacobsen

5

1 reference

26 November 2017

A Lindholm

6

1 reference

26 November 2017

Insulin Aspart Study Goup

7

1 reference

26 November 2017

1 November 2001

1 reference

Diabetes Research and Clinical Practice

26 November 2017

1 reference

26 November 2017

54

1 reference

26 November 2017

105-114

1 reference

26 November 2017

2

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900262-5

7 January 2021

Monomeric insulins obtained by protein engineering and their medical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900262-5

7 January 2021

Do insulin-treated diabetic patients use an injection-meal-interval in daily life?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900262-5

7 January 2021

Insulin receptors: binding kinetics and structure-function relationship of insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900262-5

7 January 2021

Receptor-binding region of insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900262-5

7 January 2021

Time-action profile of the insulin analogue B28Asp

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900262-5

7 January 2021

Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900262-5

7 January 2021

Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900262-5

7 January 2021

Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900262-5

7 January 2021

Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900262-5

7 January 2021

Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900262-5

7 January 2021

Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900262-5

7 January 2021

Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900262-5

7 January 2021

Use of the short-acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900262-5

7 January 2021

Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900262-5

7 January 2021

Optimal provision of daytime NPH insulin in patients using the insulin analog lispro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900262-5

7 January 2021

Optimization of evening insulin dose in patients using the short-acting insulin analog lispro.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900262-5

7 January 2021

The Diabetes Health Profile (DHP): a new instrument for assessing the psychosocial profile of insulin requiring patients--development and psychometric evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900262-5

7 January 2021

Injection-meal interval: recommendations of diabetologists and how patients handle it.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900262-5

7 January 2021

10.1016/S0168-8227(01)00262-5

Identifiers

DOI

1 reference

26 November 2017

1 reference